Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Filings indexed 396 across all filing types
Latest filing 2018-10-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically involving HLB Co., Ltd. and its stake in HLB Life Science Co., Ltd. This type of filing is used to notify the market of significant changes in shareholding (crossing thresholds), which falls under the 'Major Shareholding Notification' category.
2018-10-12 Korean
증권발행결과(자율공시)(제7회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the company's capital structure and financing activities.
2018-10-11 Korean
유상증자최종발행가액확정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from HLB Life Science regarding the final issuance price for a capital increase (rights offering). It details the number of shares, the final price per share, and the calculation methodology used to determine this price. This falls under the category of capital structure changes and financing activities, specifically related to share issuance.
2018-10-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act of South Korea. This type of filing is used to disclose significant changes in share ownership (crossing thresholds) by major shareholders or related parties. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2018-10-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. While it involves directors/major shareholders, it is specifically a disclosure of their holdings and transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided schema.
2018-10-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose changes in their shareholdings (insider trading). Based on the provided categories, this aligns with 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2018-10-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.